stella
beta
Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM — Stella
Home
/
Relapsed/Refractory Multiple Myeloma
/
Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
View on ClinicalTrials.gov
Recruiting
Back to Relapsed/Refractory Multiple Myeloma trials
Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Sanbin Wang, Kunming, Kunming, Yunnan
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow